AEB and FAS joint press conference on the Code of Good Practice
19.04.2016
On 19 April 2016 the Association of European Businesses (AEB) and the Federal Antimonopoly Service (FAS) held a joint press conference to present the Code of Good Practice in the Pharmaceutical Industry.
The main objective of the Code is the self-regulation of the pharmaceutical industry in the Russian Federation, as well as the establishment of fair, open and honest rules of competition in the pharmaceutical industry.
The CEO of the Association of European Businesses Dr. Frank Schauff made a welcoming speech. He thanked all the experts who worked on the Code of Good Practice. The Head of the Federal Antimonopoly Service Igor Artemiev talked about the main objectives of the Code and its impact on the pharmaceutical market.
Yuri Litvishchenko, Chairman of the AEB Health and Pharmaceuticals Committee, CEO, Chiesi Pharmaceutical, made gave a presentation on the main provisions of the new Code.
The press-conference was followed by a Q&A session.
Press-release can be downloaded here in RUS and ENG. The Code of Good Practice is available HERE
L-R: Yuri Litvishchenko, Chairman of the AEB Health and Pharmaceuticals Committee; Igor Artemiev, Head of the Federal Antimonopoly Service; Frank Schauff, AEB CEO.